Johnson & Johnson (JNJ) – Research Analysts’ Weekly Ratings Updates

Johnson & Johnson (NYSE: JNJ) recently received a number of ratings updates from brokerages and research firms:

• 10/23/2026 – Johnson & Johnson was downgraded by Weiss Ratings from “buy (b+)” to “buy (b-)”.
• 10/21/2026 – Johnson & Johnson was downgraded by Johnson Rice from “buy” to “hold”.
• 10/21/2026 – Johnson & Johnson was downgraded by Erste Group Bank from “buy” to “hold”.
• 10/20/2026 – Johnson & Johnson was given a new $300.00 price target by Evercore.
• 10/20/2026 – Johnson & Johnson had its “buy” rating reaffirmed by TD Cowen.
• 10/16/2026 – Johnson & Johnson had its price target raised by Wells Fargo & Company from $275.00 to $287.00. They now have an “overweight” rating on the stock.
• 10/15/2026 – Johnson & Johnson was given a new $270.00 price target by Sanford C. Bernstein.
• 10/15/2026 – Johnson & Johnson had its price target lowered by Morgan Stanley from $294.00 to $292.00. They now have an “overweight” rating on the stock.
• 10/14/2026 – Johnson & Johnson had its price target lowered by Leerink Partners from $276.00 to $272.00. They now have an “outperform” rating on the stock.
• 10/14/2026 – Johnson & Johnson had its price target lowered by Wells Fargo & Company from $282.00 to $275.00. They now have an “overweight” rating on the stock.
• 10/14/2026 – Johnson & Johnson was given a new $270.00 price target by UBS Group.
• 10/14/2026 – Johnson & Johnson had its “market perform” rating reaffirmed by Sanford C. Bernstein.
• 10/14/2026 – Johnson & Johnson had its price target lowered by Royal Bank Of Canada from $290.00 to $280.00. They now have an “outperform” rating on the stock.
• 10/8/2026 – Johnson & Johnson was upgraded by Weiss Ratings from “buy (b)” to “buy (b+)”.
• 10/7/2026 – Johnson & Johnson had its “buy” rating reaffirmed by Guggenheim. They now have a $287.00 price target on the stock.
• 10/6/2026 – Johnson & Johnson had its price target raised by Royal Bank Of Canada from $287.00 to $290.00. They now have an “outperform” rating on the stock.
• 10/5/2026 – Johnson & Johnson had its price target raised by Citigroup from $298.00 to $303.00. They now have a “buy” rating on the stock.
• 9/29/2026 – Johnson & Johnson had its “neutral” rating reaffirmed by Bank of America. They now have a $278.00 price target on the stock.
• 9/29/2026 – Johnson & Johnson had its price target raised by JPMorgan Chase & Co. from $270.00 to $285.00. They now have a “neutral” rating on the stock.
• 9/22/2026 – Johnson & Johnson had its “buy” rating reaffirmed by UBS Group.
• 9/10/2026 – Johnson & Johnson had its price target raised by HSBC from $290.00 to $320.00. They now have a “buy” rating on the stock.

Johnson & Johnson Price Performance

JNJ traded up $5.79 during trading on Wednesday, hitting $271.96. 3,247,811 shares of the company traded hands, compared to its average volume of 7,931,486. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The company has a market cap of $654.69 billion, a PE ratio of 41.21, a P/E/G ratio of 2.67 and a beta of 0.22. The stock’s 50-day simple moving average is $265.60 and its two-hundred day simple moving average is $247.46. Johnson & Johnson has a 1 year low of $185.12 and a 1 year high of $282.02.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Tuesday, October 13th. The company reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.06. The firm had revenue of $25.40 billion during the quarter, compared to analyst estimates of $25.38 billion. Johnson & Johnson had a net margin of 16.20% and a return on equity of 31.64%. Johnson & Johnson’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period last year, the firm posted $2.80 earnings per share. Johnson & Johnson has set its FY 2026 guidance at 11.050-11.150 EPS. As a group, sell-side analysts anticipate that Johnson & Johnson will post 11.12 earnings per share for the current fiscal year.

Johnson & Johnson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 24th will be issued a $1.34 dividend. The ex-dividend date is Tuesday, November 24th. This represents a $5.36 dividend on an annualized basis and a dividend yield of 2.0%. Johnson & Johnson’s payout ratio is 81.21%.

Insider Activity

In other news, EVP Elizabeth Forminard sold 15,918 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $257.00, for a total transaction of $4,090,926.00. Following the sale, the executive vice president directly owned 16,994 shares in the company, valued at approximately $4,367,458. This represents a 48.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Jennifer Taubert sold 15,000 shares of Johnson & Johnson stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $263.36, for a total value of $3,950,400.00. Following the completion of the transaction, the executive vice president owned 194,451 shares of the company’s stock, valued at approximately $51,210,615.36. This represents a 7.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 64,515 shares of company stock worth $17,271,766. 0.16% of the stock is currently owned by corporate insiders.

Johnson & Johnson (NYSE: JNJ) is a global healthcare company headquartered in New Brunswick, New Jersey. Founded in 1886, the company develops and markets products and services for patients, healthcare professionals and institutions worldwide.

Johnson & Johnson operates through two principal segments: Innovative Medicine and MedTech. Innovative Medicine focuses on pharmaceuticals for areas such as immunology, oncology, neuroscience, infectious diseases and cardiovascular conditions.